Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.

Master Sgt. Ron Bohl’s didn’t hesitate when he learned that his brother, Matthew, was battling stage 5 kidney disease, and ...

An amazing thing happened at the University of Washington Medical Center on Friday. Doctors took a kidney from Shane’s ...

Former University of Washington and NBA guard Nate Robinson is recovering after undergoing a successful kidney transplant ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

Some symptoms are felt at night which most people ignore, but these symptoms can be signs that your kidney is slowly getting ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...

Adam Turner (45) from Peterborough- who works at Hinchingbrooke Hospital- is looking to raise around £3,000 for Kidney ...

Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...

P-gp and BCRP Substrates: Avoid concomitant use of sensitive substrates of P-gp and BCRP with FILSPARI. Sparsentan may increase exposure of these transporter substrates, which may increase the risk of ...